[{"NetIncomeLoss_1_Q3_USD":-21835000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-132000.0,"OtherAssetsNoncurrent_0_Q3_USD":502000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":63434000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":12097000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":6095000.0,"Liabilities_0_Q3_USD":128531000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":8000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":10000.0,"OperatingLeaseLiability_0_Q3_USD":13097000.0,"StockholdersEquityNoteStockSplitConversionRatio1_0_Q3_pure":0.1186,"DepreciationAndAmortization_3_Q3_USD":1252000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":8472000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":2861000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":1493521.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":2727000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":1540902.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_3_Q3_USD":910000.0,"PaymentsToAcquireShortTermInvestments_3_Q3_USD":135926000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":8000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":2577000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-136284000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":2410000.0,"AssetsCurrent_0_Q3_USD":208924000.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":11973000.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":256003042.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":256520000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":795000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":530000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2340000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-21845000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-44532000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-27047000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":551000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":58007000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":23935000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":18889000.0,"EarningsPerShareBasic_3_Q3_USD":-36.76,"EarningsPerShareBasic_1_Q3_USD":-17.55,"TemporaryEquityLiquidationPreference_0_Q3_USD":256520000.0,"TemporaryEquitySharesAuthorized_0_Q3_shares":264000000.0,"AssetsFairValueDisclosure_0_Q3_USD":199413000.0,"ConvertiblePreferredStockSharesIssuedUponConversion_0_Q3_shares":30355379.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":44000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":43000.0,"AccountsReceivableNetCurrent_0_Q3_USD":4141000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-502000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-167000.0,"PreferredStockDividendsIncomeStatementImpact_3_Q3_USD":10363000.0,"PreferredStockDividendsIncomeStatementImpact_1_Q3_USD":5212000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-54903000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":9830000.0,"FairValueAdjustmentOfWarrants_1_Q3_USD":3141000.0,"FairValueAdjustmentOfWarrants_3_Q3_USD":3141000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":199400000.0,"FinancialLiabilitiesFairValueDisclosure_0_Q3_USD":5465000.0,"CommonStockSharesIssued_0_Q3_shares":1634121.0,"DeferredRevenueNoncurrent_0_Q3_USD":61083000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":154879000.0,"TemporaryEquitySharesIssued_0_Q3_shares":256003042.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q3_USD":0.0,"CommonStockValue_0_Q3_USD":1000.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":-8425000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":4473000.0,"Assets_0_Q3_USD":229127000.0,"UnrealizedGainLossOnInvestments_3_Q3_USD":53000.0,"ShareBasedCompensation_3_Q3_USD":713000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-162028000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-482000.0,"CommonStockSharesOutstanding_0_Q3_shares":1634121.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"InvestmentsFairValueDisclosure_0_Q3_USD":135979000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":5207000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-45042000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-22002000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":713000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":436000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_3_Q3_USD":24933000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_1_Q3_USD":8447000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-45710000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":2272000.0,"LiabilitiesCurrent_0_Q3_USD":40009000.0,"DeferredRevenueCurrent_0_Q3_USD":23915000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":-27115000.0,"NetIncomeLoss_3_Q3_USD":-44540000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":3580000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_3_Q3_USD":145525000.0,"ReceivablesNetCurrent_0_Q3_USD":4141000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":10000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q3_USD":1.05,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-8000.0,"LongTermDebtNoncurrent_0_Q3_USD":9877000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":5370000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":66011000.0,"NonoperatingIncomeExpense_1_Q3_USD":-3653000.0,"NonoperatingIncomeExpense_3_Q3_USD":-3496000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":527000.0,"AccountsPayableCurrent_0_Q3_USD":5264000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":63434000.0,"ShortTermInvestments_0_Q3_USD":135979000.0,"RestrictedCashAndCashEquivalents_0_Q3_USD":2577000.0,"StockholdersEquity_0_Q3_USD":-155924000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":13544000.0,"DeferredRevenue_0_Q3_USD":84998000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":764000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":5792000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":2483000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1798000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"CommonStockSharesAuthorized_0_Q3_shares":370000000.0,"OperatingIncomeLoss_3_Q3_USD":-41546000.0,"OperatingIncomeLoss_1_Q3_USD":-18349000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_3_Q3_USD":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q3_USD":0.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":210000.0,"StockRepurchasedDuringPeriodValue_3_Q3_USD":210000.0,"PaymentsForRepurchaseOfInitialPublicOffering_3_Q3_USD":2446000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":229127000.0,"OtherLiabilitiesCurrent_0_Q3_USD":164000.0,"ProfitLoss_3_Q3_USD":-44540000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-17.55,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-36.76,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":3157000.0,"OperatingExpenses_1_Q3_USD":26796000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":359000.0,"OperatingExpenses_3_Q3_USD":66479000.0,"SharePrice_0_Q3_USD":2.26,"PropertyPlantAndEquipmentGross_0_Q3_USD":8786000.0,"AmortizationOfDebtDiscountPremium_1_Q3_USD":203000.0,"AmortizationOfDebtDiscountPremium_3_Q3_USD":229000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":436000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":713000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1000000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1552000.0,"Ticker":"CCCC","CIK":"1662579","name":"C4 THERAPEUTICS, INC.","OfficialName":"C4 Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"459607469.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]